Table 1.
Somatic features before and after the intervention in the training and control groups.
| Parameters | Assessment at Baseline | Assessment at 6 Months | |
|---|---|---|---|
| Body mass (kg) | T | 71.16 (11.10); 71.50 (65.80–73.70) | 71.34 (11.90); 68.30 (64.70–74.30) |
| C | 77.06 (13.85); 78.70 (66.10–86.10) | 77.26 (13.95); 78.70 (65.10–87.00) | |
| BMI (kg/m2) | T | 27.49 (3.48); 28.28 (24.24–28.60) | 27.72 (3.92); 27.00 (25.10–29.00) |
| C | 28.54 (4.39); 28.08 (24.73–32.55) | 28.78 (4.51); 29.00 (25.10–32.50) | |
| Total fat (%) | T | 41.07 (5.97); 40.10 (39.30–45.60) | 40.46 (6.29); 39.60 (38.50–45.10) |
| C | 41.28 (6.68); 44.50 (35.80–47.50) | 41.29 (6.57); 44.20 (36.00–46.30) | |
| Lean body mass (kg) | T | 39.71 (4.42); 40.46 (37.71–41.36) | 40.18 (3.89); 40.60 (37.38–41.90) |
| C | 42.65 (4.14); 41.41 (40.45–45.61) | 42.82 (4.35); 41.34 (40.156–44.00) | |
| Total fat (kg) | T | 28.30 (7.98); 27.50 (24.39–30.74) | 28.10 (8.88); 26.96 (24.49–29.83) |
| C | 31.22 (10.13); 36.12 (22.32–37.68) | 31.31 (10.04); 36.70 (22.06–38.12) | |
| Android fat tissue (%) | T | 45.17 (8.14); 45.70 (42.70–51.80) | 43.83 (9.41); 44.00 (42.10–50.00) |
| C | 46.34 (8.16); 44.80 (39.70–54.20) | 45.90 (7.72); 45.70 (40.20–53.10) | |
| Gynoid fat tissue (%) | T | 48.09 (5.08); 50.10 (44.90–52.00) | 46.79 (4.96); 47.70 (43.40–50.50) |
| C | 45.96 (6.48); 47.30 (42.10–51.30) | 45.88 (5.66); 45.90 (43.70–50.20) |
Results are expressed as mean (SD); median (interquartile range).